UK backs studies with $44 mln fund to accelerate vaccine development

Published: Updated:
Enable Read mode
100% Font Size

Britain said on Tuesday it would back human challenge studies to accelerate the development of COVID-19 vaccines by exposing volunteers to the virus after they had received a vaccine candidate.

Visit our dedicated coronavirus site here for all the latest updates.

The government said it would invest 33.6 million pounds ($43.5 million) in the studies in partnership with Imperial College London, laboratory and trial services company hVIVO and the Royal Free London NHS Foundation Trust.

If approved by regulators and the ethics committee, the studies would start in January with results expected by May 2021, the government said.

Read More:

Cold storage hurdle for coronavirus vaccine storage may hamper efforts for the poor

Coronavirus: Russia receives renewed approval for COVID-19 vaccine trials in India

Coronavirus: When will COVID-19 vaccines be generally available in the United States?

Top Content Trending